AbbVie makes another small I&I acquisition, buying Nimble for $200Mnews2024-12-13T14:41:24+00:00December 13th, 2024|Endpoints News|
Eli Lilly has tapped telehealth startup Ro to distribute its single-dose Zepbound vialsnews2024-12-11T13:36:39+00:00December 11th, 2024|Endpoints News|
Exclusive: Angitia, a Bain-backed musculoskeletal biotech, raises $120M for trio of clinical-stage biologicsnews2024-12-11T12:00:35+00:00December 11th, 2024|Endpoints News|
Negev Labs debuts with $30M in assets, striving to build a network of psychedelic biotechsnews2024-12-11T12:00:07+00:00December 11th, 2024|Endpoints News|
New oncology biotech launches with $52M in its pocketnews2024-12-10T09:01:53+00:00December 10th, 2024|Endpoints News|
Relation and GSK to collaborate on fibrosis, osteoarthritisnews2024-12-10T00:00:37+00:00December 10th, 2024|Endpoints News|
Belharra Therapeutics sticks with lead programs, trims workforce by 40%news2024-12-09T19:31:21+00:00December 9th, 2024|Endpoints News|
Vijay Pande hands a16z biotech leadership to Vineeta Agarwalanews2024-12-09T18:49:46+00:00December 9th, 2024|Endpoints News|
Amazon Pharmacy, Ro say they help patients stick with GLP-1 drugs longernews2024-12-09T15:31:32+00:00December 9th, 2024|Endpoints News|
Dimension nabs $500M second fund for ‘still contrary’ intersection of bio and machine learningnews2024-12-09T13:00:23+00:00December 9th, 2024|Endpoints News|
